Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imasa, M. S. B
Right arrow Articles by Nevado, J. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imasa, M. S. B
Right arrow Articles by Nevado, J. B, Jr

ORIGINAL ARTICLE

Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes

Marcelo Severino B Imasa, MD1, Neil T Gomez, MD2, Jose B Nevado, Jr, MD3

1 Department of Pharmacology, University of the Philippines College of Medicine, Manila
2 Philippine Heart Center, Quezon City
3 Department of Biochemistry and Molecular Biology, University of the Philippines College of Medicine, Manila

Jose B Nevado, Jr, MD, Tel: +240 301 482 9625, Fax: +(632) 526 4197 301 451 7090, Email: jolnev2000{at}yahoo.com, 547 Pedro Gil Street, Ermita, Manila, Philippines.

ABSTRACT

Homocysteinemia is a risk factor for cardiovascular diseases. Folic acid combined with vitamins B6 and B12 is effective in lowering homocysteine levels. This randomized placebo-controlled study was designed to determine the effect of a folic acid-based supplement on secondary prevention of clinical events in non-ST-segment elevation acute coronary syndromes. The study comprised 240 patients with either unstable angina or non-ST-elevation myocardial infarction in the previous 2 weeks who were randomized to a folate group (n =116) or a placebo group (n =124). The folate group received 1 mg folic acid, 400 µg vitamin B12, and 10 mg vitamin B6 daily. Clinical outcomes within 6 months were assessed. The composite endpoint of death, nonfatal acute coronary syndrome, and serious re-hospitalization was significantly higher in the folate group; serious re-hospitalization alone was significantly higher in this group. Advanced age and diabetes increased susceptibility to the composite outcome. Folic acid-based supplementation is not beneficial and may even be harmful in the secondary prevention of cardiovascular events in patients with unstable angina and non-ST-elevation myocardial infarction. Further studies on the safety of such supplements are suggested. Controlled Clinical Trials Registry no. ISRCTN30249553.

Key Words: Unstable angina • Angina • Unstable • Folic Acid • Homocysteine • Myocardial Infraction • Randomized Controlled Trial

Asian Cardiovasc Thorac Ann 2009; 17:13-21
© 2009 by SAGE Publications
DOI: 10.1177/0218492309102494




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by SAGE Publications